Thyssenkrupp's Balancing Act: A Spin-Off Greenlight, a Solar Bet, and a Hydrogen Headache
Published on 08/10/2026 at 13:41 | Redaktion boerse-global.de
The industrial conglomerate's transformation story is playing out on multiple fronts at once. Shareholders have waved through the separation of the materials distribution arm, a renewable energy project is taking shape at one of its steel plants, and the hydrogen subsidiary has just delivered a sobering earnings update. For investors, the picture is one of measured progress punctuated by pockets of pain.
The Accelis Exit Takes Shape
Last Friday's extraordinary general meeting delivered the expected result: tk accelis, the group's materials trading and distribution business, is cleared for its own stock market listing before the year is out. The new entity brings considerable heft — roughly 15,500 employees across more than 400 locations in over 30 countries, working with around 11,000 suppliers, and generating sales of €11.4 billion. Its market position is commanding in Germany and Europe, with a number-three ranking in North America.
The mechanics of the separation have been public since early August. For every 20 Thyssenkrupp shares held, shareholders will receive one share in the new company. The parent will retain a 51 percent stake initially, preserving strategic influence even as the business gains operational independence. Registration in the commercial register is pencilled in for the end of August, with the demerger taking legal effect around the end of October.
The unit appears to be leaving the nest in decent shape. Media reports point to a 179 percent surge in adjusted earnings for the second fiscal quarter — a sign that the distribution business has momentum as it prepares to stand alone. The logic of the transaction is straightforward: a separately listed entity gives investors the option to buy into the distribution franchise directly, rather than taking exposure to the whole conglomerate.
Solar Ambitions at Andernach
Alongside the corporate restructuring, the steel division is making its own energy transition moves. The Rasselstein subsidiary, together with VSB Group, is developing an 8 megawatt-peak solar installation at the Andernach site. The project will span 5.2 hectares, accommodate roughly 12,000 modules, and generate around 8 gigawatt-hours annually, underpinned by a 20-year power purchase agreement. Construction is slated to begin in the fourth quarter of 2026, with completion targeted for mid-2027.
Should investors sell immediately? Or is it worth buying Thyssenkrupp?
There is a neat symmetry in the procurement: the project will use CO?-reduced bluemint® steel with ZM EcoProtect® Solar coating — the group deploying its own greener steel products in its own infrastructure. It is a modest step on the emissions-reduction agenda rather than a new revenue stream, but it reinforces the broader push to decarbonise steelmaking processes.
Nucera's Numbers Dampen the Mood
Not everything is moving in the right direction. Thyssenkrupp Nucera, the hydrogen electrolysis business, has swung into the red. Third-quarter revenue fell to €145 million from €184 million a year earlier. On a nine-month basis, group EBIT flipped from a positive €4 million to a negative €69 million. The company's ad-hoc disclosure attributes the higher costs to new construction projects and the termination of a contract for a US project in the gH2 segment. Revenue did come in above management's prior expectations, but the earnings deterioration is stark.
The contrast with tk accelis is instructive. One business is being released into independence on a wave of growth; another, representing the group's bet on the hydrogen economy, is still absorbing start-up costs and project risks. That tension is likely to be a central theme when the group reports its nine-month figures on 13 August. CEO Miguel Ángel López Borrego and CFO Dr. Axel Hamann will walk analysts through the numbers in a conference call starting at 11:00.
What the Charts Say
The share price has been resilient through the news flow. The stock closed Friday's session at €12.54, just 5.92 percent shy of its 52-week high of €13.34 reached in early October. Year-to-date, the gain stands at 35.27 percent, and the 30-day move is up 8.61 percent. The current level of around €12.47 sits roughly eight percent above the 50-day average of €11.55, suggesting the short-term trend remains constructive. That said, the distance to the March low of €7.10 underscores just how far the recovery has travelled.
Technical analysts are talking about a breakout above a key resistance level this week, though its durability remains to be tested. The Deutsche Bank's late-July move — lifting its price target from €14.50 to €16 with a "Buy" rating — adds a supportive voice. The bank's analyst framed the accelis spin-off as a form of special dividend for shareholders and saw roughly €2 of additional upside beyond the new target.
The market's reaction to the interim report on 13 August will likely hinge on how much of a drag Nucera proves to be on the overall result. For now, the restructuring story carries the day — but the hydrogen division's losses are a reminder that not every chapter of this transformation is going according to plan.
Ad
Thyssenkrupp Stock: New Analysis - 10 August
Fresh Thyssenkrupp information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
